In Thursday’s Web Extra the traders talk China – now growing at its slowest pace since 2005. Also Pete Najarian has more fun with Pharma.   Read More

Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!   Read More

The S&P closed 20% below its all-time high set in October, making it the last of the three major U.S. stock indexes to fall into a bear market. What's the "Word on the Street?"   Read More

In the world of nearly 400 publicly-traded biotechs, analyst coverage is especially important. Many of the firms are micro caps and when an analyst initiates coverage it can help put a baby biotech on investor and reporter radar screens.    Read More

What are the best plays when the market enters bear territory?   Read More

Paul Larson says it's time to get back into equities. The equities strategist at Morningstar says buying stocks now will set up your portfolio for a big payoff in three to five years. Larson offered CNBC his top U.S. stocks.   Read More

Following are the day’s biggest winners and losers. Find out why shares of Raytheon and Pulte popped while UPS and Cooper Tire dropped.   Read More

The Dow closed lower on Tuesday with stocks slipping on concerns about the economy after consumer confidence fell to a 16-year low. What's the "Word on the Street?"   Read More

Despite at least a couple of analysts coming out with relatively bullish post-ASCO research notes on Pfizer's oncology drug pipeline, PFE shares have fallen to yet another new low intra-day and have crossed another threshold.   Read More

This is gonna be a crazy couple of days. At 9 pm ET tonight the American Society of Clinical Oncology is putting nearly 5,000 studies on its website all at once. Although ASCO says it's all about the science and protecting the "scientific integrity" of its upcoming conference, this is, frankly, an attempt to level the playing field for Wall Street.    Read More